Vector-Borne Infections
Our vector‑borne infection solution delivers comprehensive, multiplexed detection across mosquito‑borne viral, bacterial and protozoan targets. By simultaneously identifying pathogens such as dengue, Zika, Ross River, West Nile, Japanese encephalitis, Chikungunya and Plasmodium spp., the panel provides a clear picture of potential co‑circulating infections. This broad target coverage supports surveillance and research applications by enabling confident interpretation of complex infection profiles across diverse geographic and transmission settings.
Vector-Borne Infections
Combinations of viral, bacterial, and protozoan targets with Artemisinin resistance to rapidly inform clinical interventions.
Parasites
- Plasmodium spp.
Resistance Genes
- Artemisenin resistance SNP C580Y in Plasmodium spp.
Viruses
- Dengue Virus 1
- Dengue Virus 2
- Dengue Virus 3
- Dengue Virus 4
- Barmah Forest Virus
- Chikungunya Virus
- Japanese Encephalitis
- Kunjin virus
- Murray Valley Encephalitis Virus
- Ross River Virus
- West Nile virus
- Zika Virus
Ordering Information
| Ref | Description | Pack Size | Tests |
|---|---|---|---|
| 27157S | RIDA®Plex Mosquito-Borne Infections 16 well Step 1 | 12 x 8-well Strips | 96 |
| 27157P | RIDA®Plex Mosquito-Borne Infections 16 well Step 2 | 12 x 384-well Plates | 288 |
| 40331 | RIDA®Plex L RNA Cassette | 10 Cassettes | – |
| 91600 | RIDA®Plex Positive Control Vector-Borne Panels | 10 x 2mL Tubes | – |
RIDA®Plex IVD panels are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, Great Britain, and the European Economic Area, and are included on the Australian Register of Therapeutic Goods (ARTG), the MHRA database (REF: 10541) and compliant with the European IVD Directive 98/79/EC. In the USA: For Research Use Only (RUO). For Research Use Only (RUO), not for use In diagnostic procedures. RIDA®Plex RUO panels are for Research Use Only in any jurisdiction.
